TGFB1 and COVID-19: In a recent study published in Nature, Witkowski et al. reported that in patients with severe forms of coronavirus disease 2019 (COVID-19) deranged tumor growth factor-beta (TGF-β) secretion counteracts interferon-alpha (IFN-α)-induced activation of NK cells by decreasing expression of transcription factor T-bet.